The Biden administration issued a decision on May 5, local time, stating that the United States will abandon its intellectual property patents for the new crown pneumonia vaccine.
US Secretary of Trade Katherine Tai announced the decision of the US government in a statement on the 5th.
Prior to this, American drugmakers had conducted fierce internal debates and vigorously fought back on the matter.
Dai Qi said that the government's move is to popularize safe and effective vaccines as soon as possible and end the new crown pneumonia epidemic.
She also said that the US government will continue to strengthen cooperation with the private sector and all possible partners, expand the manufacture and distribution of vaccines, and strive to increase the raw materials required to produce these vaccines.
This move by the United States may expand the global supply of new crown pneumonia vaccines and narrow the vaccination gap between rich and poor countries.
Ron Klain, director of the White House Office of the United States, said on the 2nd that intellectual property rights are part of the global shortage of new crown pneumonia vaccines, but the bigger problem lies in manufacturing.
He said that the White House will reveal more information "in the coming days."
(CCTV reporter Xu Dezhi)